The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryBlood pressure control for diabetic retinopathyFirst-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionTreatment of hypertension in peripheral arterial diseaseAntihypertensive agents for preventing diabetic kidney diseaseBlood pressure targets for hypertension in people with diabetes mellitusCalcium channel blockers versus other classes of drugs for hypertensionTreatment of hypertension in peripheral arterial diseaseAngiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney diseaseStandards of medical care in diabetes--2012Implications of recent hypertension trials for the generalist physician: whom do we treat, and how?Debate: Does it matter how you lower blood pressure?Diuretics: again the first step in the treatment of most patients with hypertensionDiabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trialsCardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesHypertension and chronic kidney disease: controversies in pathogenesis and treatmentAmlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)Identifying and slowing progressive chronic renal failureThe effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trialsHypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do BetterStandards of medical care in diabetes--2013Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.Why not prescribe the best drugs for hypertension now?Screening for Type 2 diabetes--should it be now?Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.Standards of medical care in diabetes--2010.Accelerated publication versus usual publication in 2 leading medical journalsACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.Calcium antagonists and safety: the turning of the tide.Summary of randomized trials of angiotensin converting enzyme inhibitors.Drug treatment for hypertensive patients in special situations: diabetes and hypertension.Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.Hypertension and diabetic retinopathy--what's the story?Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Management of hypertension. Ideal body weight is not realistic goal for lifestyle interventionWhat are the elements of good treatment for hypertension?Recent advances: nephrology.Efficacy of treating hypertension in women.
P2860
Q22241786-FD2AEF31-A4AF-40CF-ADBE-8735CBDD608BQ24186434-E3616903-7480-43BA-8409-7A51CD912B30Q24186647-5F86DFEB-966C-46AE-90A9-53368AC97E02Q24201969-96605127-6762-4508-A3B5-2A8C5928BC6FQ24202090-908C2C43-0FB6-49A8-825D-4814C37034ECQ24202854-7E88ED27-0862-418A-8E88-3C1161BF14CDQ24236584-10B28782-4E47-4ECA-8D7E-3745685F15C9Q24240538-DC1807FA-93A3-4BCB-BA73-3A446B18F60FQ24244197-EEBC5B02-FCFE-4B60-BA00-A943483B05D7Q24632533-35A3F589-E100-4489-8EFB-CE1C92CB5E0AQ24792362-76E379EE-B9AC-4026-976A-1BC969D38A14Q24792532-60198E0A-964F-40E7-8AA6-E1EB3A9923B3Q24806951-6CCE08B4-1430-4D20-80FA-80B94BD6D942Q26766599-1DD34E02-705F-4F8C-8E6F-AF26874E74EAQ26767278-D3AEE78F-1EA1-4265-B283-A847F05D02B7Q26851271-C630EEB7-B940-45CD-8F8B-FA81290A1CD8Q28200627-D6AECED3-6133-4733-9DD6-4CD977C6CBEBQ28344781-8EB009FF-497D-4A3E-85AB-66E174E8F1D9Q28487721-73FECEC0-BFEE-4349-B448-E8EDF31C2B19Q29399489-78750A5A-6F69-408E-9D91-E0D21E308784Q29620309-73B148D1-79D0-418C-9043-4456F86B591DQ30251636-4C567261-FEC6-4680-8887-774FF3705587Q30333019-C54DF02E-D99F-4353-A912-5F4DA5EF1F4DQ30911757-6A892349-ACC2-400E-B5AE-4DD91E4A26F9Q33239013-4D27FAC1-D9DA-4BB8-95A0-24B59BD2A006Q33554238-0240B2D2-C660-4100-9B5E-B613B3B73887Q33609417-8373505F-B85C-4A46-A473-B2253E6BDA1BQ33636677-D32924CA-0FA7-4980-9FF9-0473D2151F9CQ33643752-6A9B6AAB-3E95-49FC-8C12-6F75D0A44749Q33674543-0B5C0A42-3BC1-4532-B435-7DD92F1904C5Q33691025-23A2315A-301C-4CD1-9B77-B170BCD98231Q33697681-A5A17A6D-D733-4C0E-A06D-522B831E7AADQ33697713-F26211CD-D34F-4811-A2A6-8C30C9CA544FQ33706621-BA32DA95-D2F8-49C2-AE75-B4F8CD42271AQ33719166-1B2C4DD5-FA7E-477F-979B-7410FE5A6349Q33799767-ED7B57A0-EF49-4F92-B774-D88A828D7056Q33799983-A4E7887D-6FD9-4962-9DDD-DD69DC462253Q33805317-444D8C62-6616-4286-A9D1-EE60E6B93E96Q33811023-D5C24FB0-BE38-42E7-B908-A10F9AC5701EQ33815830-063C41D8-1953-4FE5-9844-A7E18AF06DE3
P2860
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@en
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@nl
type
label
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@en
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@nl
prefLabel
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@en
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@nl
P2093
P921
P1476
The effect of nisoldipine as c ...... ent diabetes and hypertension.
@en
P2093
Biggerstaff SL
Estacio RO
Jeffers BW
Schrier RW
P304
P356
10.1056/NEJM199803053381003
P407
P577
1998-03-01T00:00:00Z